KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Revenue (2016 - 2025)

Historic Revenue for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $5.3 billion.

  • Boston Scientific's Revenue rose 1589.56% to $5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.1 billion, marking a year-over-year increase of 1987.94%. This contributed to the annual value of $20.1 billion for FY2025, which is 1986.62% up from last year.
  • Latest data reveals that Boston Scientific reported Revenue of $5.3 billion as of Q4 2025, which was up 1589.56% from $5.1 billion recorded in Q3 2025.
  • Boston Scientific's Revenue's 5-year high stood at $5.3 billion during Q4 2025, with a 5-year trough of $2.8 billion in Q1 2021.
  • For the 5-year period, Boston Scientific's Revenue averaged around $3.8 billion, with its median value being $3.6 billion (2023).
  • Its Revenue has fluctuated over the past 5 years, first soared by 5361.96% in 2021, then surged by 367.76% in 2022.
  • Quarter analysis of 5 years shows Boston Scientific's Revenue stood at $3.1 billion in 2021, then rose by 3.68% to $3.2 billion in 2022, then grew by 14.9% to $3.7 billion in 2023, then increased by 22.44% to $4.6 billion in 2024, then rose by 15.9% to $5.3 billion in 2025.
  • Its Revenue was $5.3 billion in Q4 2025, compared to $5.1 billion in Q3 2025 and $5.1 billion in Q2 2025.